PlainRecalls
FDA Drug Moderate Class II Terminated

Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01

Reported: February 12, 2020 Initiated: January 27, 2020 #D-0830-2020

Product Description

Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01

Reason for Recall

GMP Deviations: Product bottle may be absent of desiccant.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
22,868 bottles
Distribution
Nationwide within the United States
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Desmopressin Acetate Tablets, 0.1 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories, Inc. Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc. Parisppany, NJ 07054 USA, NDC 0591-2464-01. Recalled by Teva Pharmaceuticals USA. Units affected: 22,868 bottles.
Why was this product recalled?
GMP Deviations: Product bottle may be absent of desiccant.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2020. Severity: Moderate. Recall number: D-0830-2020.